Support
Support
Search

Know Your Rhythm Resource Center

Learn more about the program and the evidence supporting early detection of AFib and other clinically actionable arrhythmias through clinical and educational resources.

Contact our team
Know your rhythm with Zio logo

Fact Sheet

Know Your Rhythm Overview.

Learn more about the program in our downloadable PDF fact sheet.
Get the PDF

Clinical Evidence

CAMELOT study unveils real-world evidence in the American Heart Journal.

The Cardiac Ambulatory Monitor EvaLuation of Outcomes and Time to Events (CAMELOT) study found that Zio long-term continuous monitoring (LTCM) service was associated with the highest diagnostic yield and lowest likelihood of retesting compared with all other monitoring services.
Read More

Press Release

New research confirms that Zio by iRhythm provides high value from a health economic perspective.

A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective.
Read the Press Release

Report

NAMCP validates Zio XT value prop to health systems and payers.

An independent third-party review, conducted by the National Association of Managed Care Physicians (NAMCP), validated evidence that shows the Zio XT long-term cardiac monitoring service contributes value to health systems and payers.
Read More

mSToPS Clinical Trial

Zio significantly improves health outcomes for patient populations.

Data published in PLOS One shows continuous monitoring leads to earlier diagnosis and prevents adverse cardiac events.
Read the Article

Steinhubl et al., PLOS ONE, 2021: Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening - mHealth Screening to Prevent Strokes (mSToPS).

Clinical Evidence

Zio facilitated a diagnosis among asymptomatic individuals.

Explore the clinical evidence supporting early arrhythmia detection and the basis for the Know Your Rhythm program.
Read the Article

*Steinhubl et al., JAMA, 2018: Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation - the mSToPS randomized clinical trial.

Clinical Evidence

Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation.

The study found that cardiac monitoring of asymptomatic individuals using Zio reduced ED visits and hospitalizations. *
Read the Analysis

*Waalen et al., Heart Rhythm O², 2020. Healthcare Resource Utilization Following ECG Sensor Patch Screening for Atrial Fibrillation.

Contact Us
Know your rhythm logo

Want to learn more?

Let’s talk and see if the Know Your Rhythm program is right for your organization.

WEB0083.01